Nexalin Technology, Inc. (NXLIW)

Market Cap	14.75M
Revenue (ttm)	174,813
Net Income (ttm)	-8.85M
Shares Out	17.42M
EPS (ttm)	-0.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,309
Open	0.0800
Previous Close	0.0750
Day's Range	0.0326 - 0.0800
52-Week Range	0.0080 - 0.7800
Beta	3.73
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2025

About NXLIW

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addictio...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Mark White
• Employees: 6
• Stock Exchange: NASDAQ
• Ticker Symbol: NXLIW
• Website: https://www.nexalin.com